Flumazenil Market
- 2026 年市場規模
- USD 21.7 Mn
- 2033 年預估規模
- USD 28.8 Mn
- 年複合成長率 CAGR
- 6.2%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Flumazenil Market, By Dose (5 ml, 10 ml), By Application (Anti Sedation, Reversing Drowsiness, Others (Hepatic Encephalopathy, Cirrhosis)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
報告摘要
Flumazenil is a benzodiazepine inhibitor Flumazenil are used as reversal drug for postsurgical sedation from benzodiazepine anesthetics. Flumazenil injection is recommended for a complete or partial reversal of the sedative effects of benzodiazepines in conscious sedation and general anesthesia in adult and pediatric populations.
Flumazenil is also designated for the management and treatment of benzodiazepine overdose in adults. It is used in reversing coma due to benzodiazepine overdose. Flumazenil is more effective in reversing coma in benzodiazepine intoxication than patients with multiple drug overdoses.
Market Dynamics
Increasing research and development for the treatment of coma using flumazenil is expected to propel growth of the global flumazenil market. For instance, according to research data published on May 9, 2021, in Journal of Medical Case Reports, researchers have reported that flumazenil has showed positive result in complete neurocognitive recovery of patient with a Glasgow Coma Score of 15. 0.25 mg of flumazenil was intravenously administered to the patient who was unresponsive with Glass Coma Score of 3. After the patient was directed with flumazenil, the patient completely recovered by neurocognitive.
Increasing cases of people facing drowsiness problem is expected to drive growth of the global flumazenil market, over the forecast period. For instance, according to data published by European Transport Workers’ Federation, in 2019 a survey done in city of London, reported that among 1353 bus drivers 37% of the drivers had to fight with drowsiness in order to stay awake. Flumazenil is used for the treatment of patients suffering from drowsiness. Flumazenil injections given through vein are more effective to treat people facing drowsiness.
Key features of the study
• This report provides an in-depth analysis of the global flumazenil market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
• It profiles leading players in the global flumazenil market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
• Key companies covered as a part of this study include Hoffmann La Roche, Akorn-Strides, LLC, Sandoz Canada Incorporated, Fresenius Kabi USA, LLC, Mylan Pharmaceuticals, Genentech, Inc., General Injectables & Vaccines Inc, Sina Health Inc, West Ward Pharmaceutical, HF Acquisition Co. LLC, DBA HealthFirst, Hikma Farmaceutica, Pfizer Laboratories Div Pfizer Inc., Physicians Total Care, Inc., and Bedford Pharmaceuticals
• Insights from this report would allow marketers and management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
• The global flumazenil market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global flumazenil market.
Market Segmentation
• By Dose
o 5 ml
o 10 ml
• By Application
o Anti – Sedation
o Reversing Drowsiness
o Others (Hepatic Encephalopathy, Cirrhosis)
• By Distribution Channel
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
• By Regional Insights
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players Insights
o Hoffmann La Roche
o Akorn-Strides, LLC
o Sandoz Canada Incorporated
o Fresenius Kabi USA, LLC
o Mylan Pharmaceuticals
o Genentech, Inc.
o General Injectables & Vaccines Inc
o Sina Health Inc
o West Ward Pharmaceutical
o HF Acquisition Co. LLC
o DBA HealthFirst
o Hikma Farmaceutica
o Pfizer Laboratories Div Pfizer Inc.
o Physicians Total Care, Inc.
o Bedford Pharmaceuticals.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Dose
Market Snippet, By Application
Market Snippet, By Distribution Channel
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Drivers
o Restraints
o Market Opportunities
o Impact Analysis
o Regulatory Scenario
o PEST Analysis
o Recent Product Launch/Approval
o Epidemiology
o Mergers and Acquisitions
4. Global Flumazenil Market, By Dose, 2026-2033 (USD Million)
o Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021-2033
Segment Trends
o 5 ml
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
o 10 ml
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
5. Global Flumazenil Market, By Application, 2026 - 2033 (USD Million)
o Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021-2033
Segment Trends
o Anti - Sedation
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
o Reversing Drowsiness
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
o Others (Hepatic Encephalopathy, Cirrhosis)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
6. Global Flumazenil Market, By Distribution Channel, 2026 - 2033 (USD Million)
o Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021-2033
Segment Trends
o Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
o Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
o Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
7. Global Flumazenil Market, By Region, 2026 - 2033 (USD Million)
o Introduction
Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2021-2033
Regional Trends
o North America
Market Size and Forecast, By Dose, 2026-2033 (USD Mn)
Market Size and Forecast, By Application, 2026-2033 (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026-2033 (USD Mn)
Market Size and Forecast, By Country, 2026-2033 (USD Mn)
o U.S.
o Canada
o Latin America
Market Size and Forecast, By Dose, 2026-2033 (USD Mn)
Market Size and Forecast, By Application, 2026-2033 (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026-2033 (USD Mn)
Market Size and Forecast, By Country, 2026-2033 (USD Mn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Market Size and Forecast, By Dose, 2026-2033 (USD Mn)
Market Size and Forecast, By Application, 2026-2033 (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026-2033 (USD Mn)
Market Size and Forecast, By Country, 2026-2033 (USD Mn)
o Germany
o U.K.
o France
o Italy
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Size and Forecast, By Dose, 2026-2033 (USD Mn)
Market Size and Forecast, By Application, 2026-2033 (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026-2033 (USD Mn)
Market Size and Forecast, By Country, 2026-2033 (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Market Size and Forecast, By Dose, 2026-2033 (USD Mn)
Market Size and Forecast, By Application, 2026-2033 (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026-2033 (USD Mn)
Market Size and Forecast, By Country, 2026-2033 (USD Mn)
o GCC
o Israel
o Rest of Middle East
o Africa
Market Size and Forecast, By Dose, 2026-2033 (USD Mn)
Market Size and Forecast, By Application, 2026-2033 (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026-2033 (USD Mn)
Market Size and Forecast, By Country, 2026-2033 (USD Mn)
o South Africa
o Central Africa
o North Africa
8. Competitive Landscape
o Company Profiles
Hoffmann La Roche
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Akorn-Strides, LLC
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Sandoz Canada Incorporated
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Fresenius Kabi USA, LLC
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Mylan Pharmaceuticals
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Genentech, Inc.
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
General Injectables & Vaccines Inc
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Sina Health Inc.
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
West Ward Pharmaceutical
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
HF Acquisition Co. LLC, DBA HealthFirst
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Hikma Farmaceutica
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Pfizer Laboratories Div Pfizer Inc.
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Physicians Total Care, Inc.
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Bedford Pharmaceuticals
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
o Analyst Views
9. Section
o References
o Research Methodology
o About us and Sales Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們